This transcript details the pathology of a specific skin lesion, confirming the diagnosis as a Pleomorphic Fibroma. The lesion is described as a hypocellular, benign tumor that often mimics a skin tag but contains atypical, hyperchromatic, stellate, or multi-nucleated cells scattered throughout the dermis. The diagnosis is supported by its low cellularity and location, which help exclude more aggressive diagnoses like Atypical Fiber Xanthoma and various sarcomas. Modern molecular evidence is highlighted, showing that Pleomorphic Fibroma is linked to Spindle Cell and Pleomorphic Lipoma through shared genetic features, specifically the loss of nuclear rb1 staining. The speaker emphasizes that while the lesion is generally benign, the presence of mitosis (including atypical mitosis) in a partially sampled lesion warrants a cautious approach, recommending follow-up excision to ensure there is no underlying deeper malignancy, such as Mixo-fibrosarcoma.
Pleomorphic Fibroma Pathology Review
0:11 Diagnosis and Appearance: The lesion is identified as a Pleomorphic Fibroma. It typically presents as a polypoid or sessile mass, often resembling a skin tag (acrochordon), found usually on the trunk or extremities.
0:25 Key Microscopic Features: The lesion contains a variable amount of hyperchromatic, atypical, often stellate or multi-nucleated cells scattered throughout the dermis.
0:36 Hypocellularity is Critical: The lesion is notably hypocellular. This is the key feature that rules out more aggressive lesions such as atypical dermatofibroma, sarcomas, or Atypical Fiber Xanthoma (AFX, which is also extremely uncommon on the trunk).
2:12 Modern Molecular Relationship: Pleomorphic Fibroma is now thought to be an intradermal, fat-free relative of Spindle Cell and Pleomorphic Lipoma.
2:22 Shared Genetic Marker (RB1 Loss): This relationship is supported by the finding of rb1 loss (loss of nuclear staining) in Pleomorphic Fibromas, a feature also seen in spindle cell and pleomorphic lipomas, due to a deletion in 13-q.
2:44 Exclusion of Malignancy: The lesions are mdm2 negative, confirming they are not related to well-differentiated liposarcoma or atypical lipomatous tumor.
3:03 Overlapping Morphology: The fibroma occasionally shows overlapping features with pleomorphic lipoma, such as ropey collagen, myxoid change, and sometimes small clusters of adipocytes in the dermis.
3:37 Management Caveat (Mitosis): Though benign, if mitosis (especially atypical mitosis) is observed, and the sample is only a partial biopsy (transected at the base), the pathologist recommends a small follow-up excision.
3:50 Ruling Out Deeper Lesions: This recommended excision is primarily to ensure the biopsy is not just the top portion of a deeper, potentially malignant lesion, such as a Mixo-fibrosarcoma.
4:42 Confirmation via IHC: If needed for confirmation, rb1 immunostaining can be performed to look for nuclear loss.
4:53 Key Takeaway: Pleomorphic Fibroma is a benign lesion usually requiring no further treatment, unless the presence of worrisome features (mitosis, partial sample) necessitates an excision to rule out underlying pathology.